Literature DB >> 10875442

Initial studies with high resolution TEM and electron energy loss spectroscopy studies of ferritin cores extracted from brains of patients with progressive supranuclear palsy and Alzheimer disease.

C Quintana1, M Lancin, C Marhic, M Pérez, J Martin-Benito, J Avila, J L Carrascosa.   

Abstract

Studies of crystallographic structure and composition of core nanocrystals of ferritin bound to aberrant tau filaments extracted from progressive supranuclear Palsy (PSP) and Alzheimer disease (AD) brain tissues were performed using high resolution transmission electron microscopy (HRTEM) and electron energy loss spectroscopy (EELS). The results were compared with those obtained from synthetic Fe3O4 crystal (magnetite) and horse spleen ferritin cores. Core dimensions of ferritin molecules from PSP and AD were similar to those found in normal brain. Ferritin cores nanocrystals in AD seems to have less ordered structure than in PSP. Some nanocrystals did not have the hexagonal ferrihydrite structure generally found in healthy ferritin but rather a cubic structure similar to magnetite, a crystalline form in which both Fe2+ and Fe3+ are present. The presence of ferrous ion, Fe2+, may indicate some dysfunction in these pathological ferritins that might contribute to production of free radicals via the Fenton reaction involved in neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10875442

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  8 in total

1.  Magnetic iron compounds in the human brain: a comparison of tumour and hippocampal tissue.

Authors:  Franziska Brem; Ann M Hirt; Michael Winklhofer; Karl Frei; Yasuhiro Yonekawa; Heinz-Gregor Wieser; Jon Dobson
Journal:  J R Soc Interface       Date:  2006-12-22       Impact factor: 4.118

2.  Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients.

Authors:  Dimitri Hautot; Quentin A Pankhurst; Chris M Morris; Andrew Curtis; John Burn; Jon Dobson
Journal:  Biochim Biophys Acta       Date:  2006-10-06

Review 3.  Alteration of Iron Concentration in Alzheimer's Disease as a Possible Diagnostic Biomarker Unveiling Ferroptosis.

Authors:  Eleonora Ficiarà; Zunaira Munir; Silvia Boschi; Maria Eugenia Caligiuri; Caterina Guiot
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

Review 4.  Physiological origin of biogenic magnetic nanoparticles in health and disease: from bacteria to humans.

Authors:  Oksana Gorobets; Svitlana Gorobets; Marceli Koralewski
Journal:  Int J Nanomedicine       Date:  2017-06-12

5.  Neurofilament Light Chain (NF-L) Stimulates Lipid Peroxidation to Neuronal Membrane through Microglia-Derived Ferritin Heavy Chain (FTH) Secretion.

Authors:  Li Gong; Qiuyue Yu; Haichao Wang; Chenhaoyi Xu; Yunxiao Dou; Bingjie Mao; Yanxin Zhao
Journal:  Oxid Med Cell Longev       Date:  2022-03-24       Impact factor: 6.543

6.  3D morphology of the human hepatic ferritin mineral core: new evidence for a subunit structure revealed by single particle analysis of HAADF-STEM images.

Authors:  Ying-Hsi Pan; Kasim Sader; Jonathan J Powell; Andrew Bleloch; Mhairi Gass; John Trinick; Alice Warley; Andy Li; Rik Brydson; Andy Brown
Journal:  J Struct Biol       Date:  2008-12-13       Impact factor: 2.867

7.  Pinocembrin protects against β-amyloid-induced toxicity in neurons through inhibiting receptor for advanced glycation end products (RAGE)-independent signaling pathways and regulating mitochondrion-mediated apoptosis.

Authors:  Rui Liu; Cai-Xia Wu; Dan Zhou; Fan Yang; Shuo Tian; Li Zhang; Tian-Tai Zhang; Guan-Hua Du
Journal:  BMC Med       Date:  2012-09-18       Impact factor: 8.775

Review 8.  Metal and complementary molecular bioimaging in Alzheimer's disease.

Authors:  Nady Braidy; Anne Poljak; Christopher Marjo; Helen Rutlidge; Anne Rich; Tharusha Jayasena; Nibaldo C Inestrosa; Perminder Sachdev
Journal:  Front Aging Neurosci       Date:  2014-07-15       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.